Ornek, NurgulOrnek, KemalErbahceci, Inci Elif2020-06-252020-06-252016Örnek N., Örnek K., Erbahçeci İ. E. (2016). Retinitis Pigmentozaya İkincil İnatçı Maküla Ödeminde Deksametazon İntravitreal İmplant (Ozurdex). Türk Oftalmoloji Dergisi, 46(4), 179 - 181.1300-06592147-2661https://doi.org/10.4274/tjo.60437https://hdl.handle.net/20.500.12587/6527Ornek, Nurgul/0000-0003-3068-1831Macular edema (ME) in retinitis pigmentosa (RP) often impairs central vision dramatically. A 41-year-old woman diagnosed with RP was referred to our outpatient clinic due to severe visual deterioration in both eyes. The patient was treated with topical carbonic anhydrase inhibitors, topical corticosteroids and intravitreal triamcinolone acetonide injections, but her ME recurred. Intravitreal 0.7 mg dexamethasone implant (Ozurdex, Allergan) was administered into both eyes without complications. On the fourth day after both injections, visual acuity improved and ME almost totally resolved. No recurrence was observed at follow-up six months later.eninfo:eu-repo/semantics/openAccessMacular edemaretinitis pigmentosadexamethasone implantIntravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis PigmentosaArticle46417918110.4274/tjo.604372-s2.0-8498348883028058154N/AtrdizinikyokturWOS:000393279900007N/A